Affinage

MED29

Mediator of RNA polymerase II transcription subunit 29 · UniProt Q9NX70

Length
200 aa
Mass
21.1 kDa
Annotated
2026-04-28
17 papers in source corpus 8 papers cited in narrative 8 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

MED29 is a subunit of the Mediator transcriptional coactivator complex that functions as a context-dependent transcriptional regulator, acting as a suppressor of MAP kinase pathway-mediated transcription (via SRE and AP-1 reporters) in some settings and as a promoter of cell proliferation, migration, and epithelial-mesenchymal transition in cancers with MED29 amplification or upregulation (PMID:15555573, PMID:21225629, PMID:35526007, PMID:39462350). In pancreatic cancer cells harboring 19q13 amplification, MED29 is required for cell viability, and its silencing causes G0-G1 arrest and apoptosis, whereas forced overexpression in low-expressing cells suppresses tumor growth in vivo, revealing dose- and context-dependent oncogenic versus tumor-suppressive activities (PMID:17332321, PMID:21225629). MED29 is essential for neurodevelopment: biallelic loss-of-function variants cause pontocerebellar hypoplasia with cataracts in humans, and knockdown in zebrafish and mouse models impairs cerebellar GABAergic neuron development, neurite outgrowth, and embryonic neuronal migration (PMID:40745490).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2004 Medium

    Establishing MED29 as a Mediator subunit with transcriptional suppressor activity resolved its molecular identity and initial function, showing it could inhibit SRE- and AP-1-dependent transcription linked to MAPK signaling.

    Evidence Gal4-DBD fusion reporter assays and overexpression in COS-7 cells

    PMID:15555573

    Open questions at the time
    • Overexpression-only approach; endogenous loss-of-function not tested
    • No direct biochemical demonstration of incorporation into Mediator complex
    • Suppressor activity not tested on endogenous target genes
  2. 2004 High

    Demonstrating that an endogenous Mediator sub-complex (CRSP/Med2) retains coactivator function for certain activators but not others established the principle of promoter-selective transcription through combinatorial subunit composition, the framework within which MED29 operates.

    Evidence Biochemical purification of endogenous complex, in vitro transcription on chromatin templates, EM 3D reconstruction

    PMID:15175162

    Open questions at the time
    • MED29-specific contribution to sub-complex selectivity not individually dissected
    • In vitro system may not capture full in vivo regulatory complexity
  3. 2007 Medium

    Linking MED29 amplification at 19q13 to pancreatic cancer cell survival established its first disease-relevant function, showing that silencing MED29 in amplified cells causes G0-G1 arrest and apoptosis while non-amplified cells are unaffected.

    Evidence High-throughput RNAi screen, FISH, flow cytometry in PANC-1 vs. MiaPaca-2 cells

    PMID:17332321

    Open questions at the time
    • Mechanism by which MED29 drives survival (direct transcriptional targets) not identified
    • Amplicon contains other genes; MED29-specific contribution not fully isolated
  4. 2011 High

    Demonstrating that MED29 knockdown reduces migration and invasion while overexpression in low-expressing cells suppresses tumors in vivo resolved the apparent paradox by establishing context-dependent oncogenic and tumor-suppressive roles, with differential regulation of cell cycle and division genes.

    Evidence RNAi and lentiviral overexpression, migration/invasion/colony assays, xenograft model, gene expression microarray

    PMID:21225629

    Open questions at the time
    • Direct transcriptional targets mediating context switch not identified by ChIP
    • Mechanism determining whether MED29 acts as activator vs. suppressor remains unclear
  5. 2022 High

    Delineating two upstream regulatory axes — tRNA fragment AS-tDR-007333 activating MED29 via HSPB1-dependent chromatin remodeling (H3K4me1/H3K27ac) and ELK4 transcription factor binding — revealed how MED29 expression is epigenetically and transcriptionally controlled to promote NSCLC proliferation.

    Evidence ChIP, luciferase reporter, RNA pulldown, mass spectrometry, RIP, Co-IP in NSCLC cells

    PMID:35526007

    Open questions at the time
    • Whether these regulatory axes operate in non-lung cancer contexts is unknown
    • Downstream transcriptional program activated by MED29 in NSCLC not mapped
  6. 2024 Medium

    Placing MED29 downstream of CHRDL1-MAPK signaling as an EMT driver in oral squamous cell carcinoma extended the MAPK-MED29 regulatory axis to a new cancer type and directly linked MED29 to EMT and metastasis.

    Evidence RT-qPCR, Western blot, Transwell assays, tail vein lung metastasis model in nude mice

    PMID:39462350

    Open questions at the time
    • Single lab study; independent confirmation in OSCC needed
    • Direct MED29 target genes driving EMT not identified
    • Whether MED29 directly or indirectly promotes EMT transcription factor expression is unresolved
  7. 2025 High

    Identifying biallelic MED29 loss-of-function as the cause of pontocerebellar hypoplasia with cataracts, validated by rescue in zebrafish and neuronal migration defects in mouse, established MED29 as essential for neurodevelopment and linked it to a Mendelian disorder.

    Evidence Whole-exome sequencing in human families, morpholino knockdown with WT rescue in zebrafish, shRNA in mouse hippocampal neurons with in utero electroporation

    PMID:40745490

    Open questions at the time
    • Transcriptional targets of MED29 in developing neurons not identified
    • Whether the p.Leu139Pro variant disrupts Mediator complex assembly or specific activator interactions is unknown
    • Cataract mechanism not explored
  8. 2025 Medium

    Demonstrating that endogenously tagged C. elegans MDT-29 concentrates in discrete nuclear foci in germ cells and that its germline-specific depletion expands the stem cell pool and reduces apoptosis established a conserved role in restricting germ cell proliferation.

    Evidence Endogenous tagging, live imaging, germline-specific RNAi, stem cell counting and apoptosis assays in C. elegans (preprint)

    PMID:bio_10.1101_2025.02.14.638312

    Open questions at the time
    • Preprint not yet peer-reviewed
    • Nature of discrete nuclear foci (relationship to transcription sites or other condensates) uncharacterized
    • Whether germline stem cell regulation is Mediator complex-dependent or a moonlighting function is unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • The direct transcriptional targets and chromatin-level mechanism by which MED29 exerts its context-dependent activator versus suppressor function remain unresolved, as do the structural basis of its integration into Mediator sub-complexes and the determinants of its tissue-specific essentiality.
  • No genome-wide ChIP-seq or CUT&RUN for MED29 occupancy at target promoters
  • No structural data for MED29 within the Mediator complex
  • Molecular basis of context-dependent oncogene vs. tumor suppressor switch uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 4
Localization
GO:0005634 nucleus 2
Pathway
R-HSA-74160 Gene expression (Transcription) 4 R-HSA-1643685 Disease 3 R-HSA-1266738 Developmental Biology 1
Partners
CHRDL1ELK4HSPB1
Complex memberships
Mediator complex

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2004 MED29 (IXL) was identified as a new subunit of the mammalian Mediator complex and functions as a transcriptional suppressor; IXL protein localizes to nucleus and cytoplasm in COS-7 cells, and overexpression inhibits transcriptional activities of SRE and AP-1, suggesting a role in suppressing MAP kinase signaling pathway-mediated transcription. Gal4-DBD fusion reporter assay, overexpression in COS-7 cells, Northern blot, subcellular localization Biochemical and biophysical research communications Medium 15555573
2004 The human CRSP/Med complex exists in a stable endogenous form (CRSP/Med2) that specifically lacks Med220 and Med70 subunits; this sub-complex retains transcriptional coactivator activity for VP16, Sp1, and Sp1/SREBP-1a but cannot support vitamin D receptor-dependent transcription, demonstrating promoter-selective function via combinatorial subunit assembly. Biochemical isolation of endogenous complex, in vitro transcription on chromatin templates, electron microscopy and single-particle 3D reconstruction (31 Å resolution) Molecular cell High 15175162
2007 MED29 (IXL) is amplified and overexpressed in pancreatic cancer cells with 19q13 amplification; RNAi-mediated silencing of MED29 in PANC-1 cells (amplified) but not MiaPaca-2 cells (non-amplified) significantly decreased cell viability and induced G0-G1 cell cycle arrest and increased apoptosis, establishing MED29 as a cell survival regulator in amplified cancer cells. High-throughput RNAi loss-of-function screen, FISH copy number analysis, qRT-PCR, cell viability assay, flow cytometry Cancer research Medium 17332321
2011 MED29 silencing in PANC-1 pancreatic cancer cells (high MED29 expression) decreased migration, invasion, and colony formation; conversely, lentiviral MED29 overexpression in NIH/3T3 and MIAPaCa-2 cells (low endogenous expression) decreased proliferation and dramatically suppressed tumor growth in vivo, with gene expression analysis revealing differential regulation of cell cycle and cell division genes, indicating context-dependent oncogenic and tumor suppressive roles. RNAi knockdown, lentiviral overexpression, scratch/migration assay, invasion assay, colony formation assay, subcutaneous xenograft mouse model, gene expression microarray International journal of cancer High 21225629
2022 The tRNA-derived fragment AS-tDR-007333 activates MED29 expression through two mechanisms: (1) binding to HSPB1, which enhances H3K4me1 and H3K27ac marks at the MED29 promoter; (2) stimulating ELK4 transcription factor expression, which directly binds the MED29 promoter and increases its transcription. Elevated MED29 expression downstream of these axes promotes NSCLC cell proliferation and migration. ChIP assay, luciferase reporter assay, RNA pulldown, mass spectrometry, RIP, Western blot, Co-IP, gain/loss-of-function experiments in vitro and in vivo Journal of hematology & oncology High 35526007
2024 MED29 promotes epithelial-mesenchymal transition (EMT), invasion, and migration in oral squamous cell carcinoma (OSCC); CHRDL1 inhibits MED29 expression via suppression of the MAPK signaling pathway, thereby restraining EMT and metastasis in vitro and in vivo. RT-qPCR, Western blot, scratch assay, Transwell invasion/migration assay, immunofluorescence, tail vein lung metastasis nude mouse model Molecular medicine (Cambridge, Mass.) Medium 39462350
2025 Biallelic loss-of-function MED29 variants (p.Leu139Pro) cause pontocerebellar hypoplasia with cataracts; MED29 morpholino knockdown in zebrafish impaired cerebellar GABAergic neuron development and locomotion, rescued by human wild-type MED29; shRNA knockdown in mouse hippocampal neurons decreased neurite length and arborization in vitro, and caused defective embryonic neuronal migration in vivo. Whole-exome sequencing, Sanger validation, morpholino knockdown in zebrafish with wild-type rescue, shRNA knockdown in mouse hippocampal neurons (in vitro and in vivo electroporation), locomotion assay, immunostaining European journal of human genetics : EJHG High 40745490
2025 In C. elegans, endogenously-tagged MDT-29/MED29 is ubiquitously expressed and concentrated in discrete foci within germ cell nuclei; germline-specific depletion of MDT-29 during larval development increases fecundity by expanding the germline stem cell pool and decreasing germ cell apoptosis, establishing MED29 as a regulator of germ cell behavior and progeny production. Endogenous tagging, live imaging, germline-specific RNAi/depletion, germline stem cell counting, apoptosis assays, fecundity assays bioRxivpreprint Medium bio_10.1101_2025.02.14.638312

Source papers

Stage 0 corpus · 17 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2022 A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1/MED29 and ELK4/MED29 axes. Journal of hematology & oncology 95 35526007
2014 The Arabidopsis mediator complex subunits MED16, MED14, and MED2 regulate mediator and RNA polymerase II recruitment to CBF-responsive cold-regulated genes. The Plant cell 95 24415770
2007 Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification. Cancer research 63 17332321
2004 Structure and function of CRSP/Med2; a promoter-selective transcriptional coactivator complex. Molecular cell 55 15175162
2017 Mediator Complex Subunits MED2, MED5, MED16, and MED23 Genetically Interact in the Regulation of Phenylpropanoid Biosynthesis. The Plant cell 49 29203634
2018 Functional diversification accompanies gene family expansion of MED2 homologs in Candida albicans. PLoS genetics 28 29630599
2005 Reevaluation of the role of the med-1 and med-2 genes in specifying the Caenorhabditis elegans endoderm. Genetics 26 15998721
2011 MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer. International journal of cancer 24 21225629
2021 Mediator Subunits MED16, MED14, and MED2 Are Required for Activation of ABRE-Dependent Transcription in Arabidopsis. Frontiers in plant science 15 33777083
2004 IXL, a new subunit of the mammalian Mediator complex, functions as a transcriptional suppressor. Biochemical and biophysical research communications 10 15555573
2020 Candida glabrata Yap6 Recruits Med2 To Alter Glycerophospholipid Composition and Develop Acid pH Stress Resistance. Applied and environmental microbiology 9 33036991
2024 CHRDL1 inhibits OSCC metastasis via MAPK signaling-mediated inhibition of MED29. Molecular medicine (Cambridge, Mass.) 7 39462350
2024 ERD14 regulation by the HY5- or HY5-MED2 module mediates the cold signal transduction of asparagus bean. The Plant journal : for cell and molecular biology 6 39589925
1999 Disruption and functional analysis of seven ORFs on chromosome IV: YDL057w, YDL012c, YDL010w, YDL009c, YDL008w (APC11), YDL005c (MED2) and YDL003w (MCD1). Yeast (Chichester, England) 6 10487928
2020 Yeast MED2 is involved in the endoplasmic reticulum stress response and modulation of the replicative lifespan. Mechanisms of ageing and development 4 33045248
2025 Biallelic MED29 variants cause pontocerebellar hypoplasia with cataracts. European journal of human genetics : EJHG 2 40745490
2006 mED2--a novel gene involved in mouse embryonic development. Yi chuan xue bao = Acta genetica Sinica 1 16939003